APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioassay and Potency Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bioassay and Potency Testing Market Analysis and Forecast 2026-2032

16 April 2026210 pages

Choose your research edition.

Industry ResearchBioassay and Potency Testing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioassay and Potency Testing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Bioassay and Potency Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioassay and Potency Testing Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Bioassay and Potency Testing Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Bioassay and Potency Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bioassay and Potency Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bioassay and Potency Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bioassay and Potency Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bioassay and Potency Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bioassay and Potency Testing include Eurofins, Vimta Labs Ltd., WaveCyte BioLabs, Reaction Biology, Charles River Laboratories, Intertek, Pacific BioLabs, FyoniBio and Svar Life Science, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bioassay and Potency Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bioassay and Potency Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Bioassay and Potency Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bioassay and Potency Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bioassay and Potency Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bioassay and Potency Testing revenue, projected growth trends, production technology, application and end-user industry.

Bioassay and Potency Testing Segment by Company

Eurofins

Vimta Labs Ltd.

WaveCyte BioLabs

Reaction Biology

Charles River Laboratories

Intertek

Pacific BioLabs

FyoniBio

Svar Life Science

Solvias

Bioassay GmbH

Clean Cells

Bioassay and Potency Testing Segment by Type

In Vitro Assay

In Vivo Assay

Bioassay and Potency Testing Segment by Application

Drug Development

Scientific Research

Other

Bioassay and Potency Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioassay and Potency Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioassay and Potency Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioassay and Potency Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bioassay and Potency Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bioassay and Potency Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bioassay and Potency Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bioassay and Potency Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. In Vitro Assay Major Player Table 3. In Vivo Assay Major Player Table 4. Global Bioassay and Potency Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Drug Development Major Player Table 6. Scientific Research Major Player Table 7. Other Major Player Table 8. Bioassay and Potency Testing Industry Trends Table 9. Bioassay and Potency Testing Industry Drivers Table 10. Bioassay and Potency Testing Industry Opportunities and Challenges Table 11. Bioassay and Potency Testing Industry Restraints Table 12. Global Bioassay and Potency Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Bioassay and Potency Testing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Bioassay and Potency Testing Market Share by Region (2021-2026) Table 15. Global Bioassay and Potency Testing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Bioassay and Potency Testing Market Share by Region (2027-2032) Table 17. Global Bioassay and Potency Testing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Bioassay and Potency Testing Revenue Market Share by Players (2021-2026) Table 19. Global Bioassay and Potency Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Bioassay and Potency Testing Key Players Headquarters & Area Served Table 21. Global Bioassay and Potency Testing Players, Product Type & Application Table 22. Global Bioassay and Potency Testing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Bioassay and Potency Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Bioassay and Potency Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bioassay and Potency Testing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Bioassay and Potency Testing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Bioassay and Potency Testing Revenue Market Share by Type (2021-2026) Table 29. Global Bioassay and Potency Testing Revenue Market Share by Type (2027-2032) Table 30. Global Bioassay and Potency Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Bioassay and Potency Testing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Bioassay and Potency Testing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Bioassay and Potency Testing Revenue Market Share by Application (2021-2026) Table 34. Global Bioassay and Potency Testing Revenue Market Share by Application (2027-2032) Table 35. Eurofins Company Information Table 36. Eurofins Business Overview Table 37. Eurofins Bioassay and Potency Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Eurofins Bioassay and Potency Testing Product Portfolio Table 39. Eurofins Recent Development Table 40. Vimta Labs Ltd. Company Information Table 41. Vimta Labs Ltd. Business Overview Table 42. Vimta Labs Ltd. Bioassay and Potency Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Vimta Labs Ltd. Bioassay and Potency Testing Product Portfolio Table 44. Vimta Labs Ltd. Recent Development Table 45. WaveCyte BioLabs Company Information Table 46. WaveCyte BioLabs Business Overview Table 47. WaveCyte BioLabs Bioassay and Potency Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. WaveCyte BioLabs Bioassay and Potency Testing Product Portfolio Table 49. WaveCyte BioLabs Recent Development Table 50. Reaction Biology Company Information Table 51. Reaction Biology Business Overview Table 52. Reaction Biology Bioassay and Potency Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Reaction Biology Bioassay and Potency Testing Product Portfolio Table 54. Reaction Biology Recent Development Table 55. Charles River Laboratories Company Information Table 56. Charles River Laboratories Business Overview Table 57. Charles River Laboratories Bioassay and Potency Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Charles River Laboratories Bioassay and Potency Testing Product Portfolio Table 59. Charles River Laboratories Recent Development Table 60. Intertek Company Information Table 61. Intertek Business Overview Table 62. Intertek Bioassay and Potency Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Intertek Bioassay and Potency Testing Product Portfolio Table 64. Intertek Recent Development Table 65. Pacific BioLabs Company Information Table 66. Pacific BioLabs Business Overview Table 67. Pacific BioLabs Bioassay and Potency Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pacific BioLabs Bioassay and Potency Testing Product Portfolio Table 69. Pacific BioLabs Recent Development Table 70. FyoniBio Company Information Table 71. FyoniBio Business Overview Table 72. FyoniBio Bioassay and Potency Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. FyoniBio Bioassay and Potency Testing Product Portfolio Table 74. FyoniBio Recent Development Table 75. Svar Life Science Company Information Table 76. Svar Life Science Business Overview Table 77. Svar Life Science Bioassay and Potency Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Svar Life Science Bioassay and Potency Testing Product Portfolio Table 79. Svar Life Science Recent Development Table 80. Solvias Company Information Table 81. Solvias Business Overview Table 82. Solvias Bioassay and Potency Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Solvias Bioassay and Potency Testing Product Portfolio Table 84. Solvias Recent Development Table 85. Bioassay GmbH Company Information Table 86. Bioassay GmbH Business Overview Table 87. Bioassay GmbH Bioassay and Potency Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Bioassay GmbH Bioassay and Potency Testing Product Portfolio Table 89. Bioassay GmbH Recent Development Table 90. Clean Cells Company Information Table 91. Clean Cells Business Overview Table 92. Clean Cells Bioassay and Potency Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Clean Cells Bioassay and Potency Testing Product Portfolio Table 94. Clean Cells Recent Development Table 95. North America Bioassay and Potency Testing Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Bioassay and Potency Testing Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Bioassay and Potency Testing Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Bioassay and Potency Testing Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Bioassay and Potency Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Bioassay and Potency Testing Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Bioassay and Potency Testing Revenue by Country (US$ Million) & (2027-2032) Table 102. Europe Bioassay and Potency Testing Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Bioassay and Potency Testing Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Bioassay and Potency Testing Revenue by Application (2021-2026) & (US$ Million) Table 105. Europe Bioassay and Potency Testing Revenue by Application (2027-2032) & (US$ Million) Table 106. Europe Bioassay and Potency Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Bioassay and Potency Testing Revenue by Country (2021-2026) & (US$ Million) Table 108. Europe Bioassay and Potency Testing Revenue by Country (US$ Million) & (2027-2032) Table 109. China Bioassay and Potency Testing Revenue by Type (2021-2026) & (US$ Million) Table 110. China Bioassay and Potency Testing Revenue by Type (2027-2032) & (US$ Million) Table 111. China Bioassay and Potency Testing Revenue by Application (2021-2026) & (US$ Million) Table 112. China Bioassay and Potency Testing Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Bioassay and Potency Testing Revenue by Type (2021-2026) & (US$ Million) Table 114. Asia Bioassay and Potency Testing Revenue by Type (2027-2032) & (US$ Million) Table 115. Asia Bioassay and Potency Testing Revenue by Application (2021-2026) & (US$ Million) Table 116. Asia Bioassay and Potency Testing Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Bioassay and Potency Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Asia Bioassay and Potency Testing Revenue by Region (US$ Million) & (2021-2026) Table 119. Asia Bioassay and Potency Testing Revenue by Region (US$ Million) & (2027-2032) Table 120. SAMEA Bioassay and Potency Testing Revenue by Type (2021-2026) & (US$ Million) Table 121. SAMEA Bioassay and Potency Testing Revenue by Type (2027-2032) & (US$ Million) Table 122. SAMEA Bioassay and Potency Testing Revenue by Application (2021-2026) & (US$ Million) Table 123. SAMEA Bioassay and Potency Testing Revenue by Application (2027-2032) & (US$ Million) Table 124. SAMEA Bioassay and Potency Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. SAMEA Bioassay and Potency Testing Revenue by Country (2021-2026) & (US$ Million) Table 126. SAMEA Bioassay and Potency Testing Revenue by Country (US$ Million) & (2027-2032) Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Bioassay and Potency Testing Image Figure 2. Global Bioassay and Potency Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioassay and Potency Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. In Vitro Assay Image Figure 5. In Vivo Assay Image Figure 6. Global Bioassay and Potency Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Bioassay and Potency Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Drug Development Image Figure 9. Scientific Research Image Figure 10. Other Image Figure 11. Global Bioassay and Potency Testing Market Size (US$ Million) & (2021-2032) Figure 12. Global Bioassay and Potency Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Bioassay and Potency Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Bioassay and Potency Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Bioassay and Potency Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Bioassay and Potency Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Bioassay and Potency Testing Revenue Market Share by Type (2021-2032) Figure 19. Global Bioassay and Potency Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Bioassay and Potency Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Bioassay and Potency Testing Revenue Market Share by Application (2021-2032) Figure 22. North America Bioassay and Potency Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Bioassay and Potency Testing Revenue Share by Type (2021-2032) Figure 24. North America Bioassay and Potency Testing Revenue Share by Application (2021-2032) Figure 25. North America Bioassay and Potency Testing Revenue Share by Country (2021-2032) Figure 26. United States Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Bioassay and Potency Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Bioassay and Potency Testing Revenue Share by Type (2021-2032) Figure 31. Europe Bioassay and Potency Testing Revenue Share by Application (2021-2032) Figure 32. Europe Bioassay and Potency Testing Revenue Share by Country (2021-2032) Figure 33. Germany Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Bioassay and Potency Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Bioassay and Potency Testing Revenue Share by Type (2021-2032) Figure 43. China Bioassay and Potency Testing Revenue Share by Application (2021-2032) Figure 44. Asia Bioassay and Potency Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Bioassay and Potency Testing Revenue Share by Type (2021-2032) Figure 46. Asia Bioassay and Potency Testing Revenue Share by Application (2021-2032) Figure 47. Asia Bioassay and Potency Testing Revenue Share by Region (2021-2032) Figure 48. Japan Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Bioassay and Potency Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Bioassay and Potency Testing Revenue Share by Type (2021-2032) Figure 56. SAMEA Bioassay and Potency Testing Revenue Share by Application (2021-2032) Figure 57. SAMEA Bioassay and Potency Testing Revenue Share by Country (2021-2032) Figure 58. Brazil Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Bioassay and Potency Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • In Vitro Assay
  • In Vivo Assay
Applications
  • Drug Development
  • Scientific Research
  • Other
Companies covered
  • Eurofins
  • Vimta Labs Ltd.
  • WaveCyte BioLabs
  • Reaction Biology
  • Charles River Laboratories
  • Intertek
  • Pacific BioLabs
  • FyoniBio
  • Svar Life Science
  • Solvias
  • Bioassay GmbH
  • Clean Cells

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bioassay and Potency Testing Market by Type
  3. 1.2.1 Global Bioassay and Potency Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 In Vitro Assay
  5. 1.2.3 In Vivo Assay
  6. 1.3 Bioassay and Potency Testing Market by Application
  7. 1.3.1 Global Bioassay and Potency Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Drug Development
  9. 1.3.3 Scientific Research
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Bioassay and Potency Testing Market Dynamics
  1. 2.1 Bioassay and Potency Testing Industry Trends
  2. 2.2 Bioassay and Potency Testing Industry Drivers
  3. 2.3 Bioassay and Potency Testing Industry Opportunities and Challenges
  4. 2.4 Bioassay and Potency Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bioassay and Potency Testing Market Perspective (2021-2032)
  2. 3.2 Global Bioassay and Potency Testing Growth Trends by Region
  3. 3.2.1 Global Bioassay and Potency Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bioassay and Potency Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Bioassay and Potency Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bioassay and Potency Testing Revenue by Players
  2. 4.1.1 Global Bioassay and Potency Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Bioassay and Potency Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bioassay and Potency Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bioassay and Potency Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bioassay and Potency Testing Key Players Headquarters & Area Served
  7. 4.4 Global Bioassay and Potency Testing Players, Product Type & Application
  8. 4.5 Global Bioassay and Potency Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bioassay and Potency Testing Market CR5 and HHI
  11. 4.6.3 2025 Bioassay and Potency Testing Tier 1, Tier 2, and Tier 3
5 Bioassay and Potency Testing Market Size by Type
  1. 5.1 Global Bioassay and Potency Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bioassay and Potency Testing Revenue by Type (2021-2032)
  3. 5.3 Global Bioassay and Potency Testing Revenue Market Share by Type (2021-2032)
6 Bioassay and Potency Testing Market Size by Application
  1. 6.1 Global Bioassay and Potency Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bioassay and Potency Testing Revenue by Application (2021-2032)
  3. 6.3 Global Bioassay and Potency Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins
  2. 7.1.1 Eurofins Company Information
  3. 7.1.2 Eurofins Business Overview
  4. 7.1.3 Eurofins Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Bioassay and Potency Testing Product Portfolio
  6. 7.1.5 Eurofins Recent Developments
  7. 7.2 Vimta Labs Ltd.
  8. 7.2.1 Vimta Labs Ltd. Company Information
  9. 7.2.2 Vimta Labs Ltd. Business Overview
  10. 7.2.3 Vimta Labs Ltd. Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Vimta Labs Ltd. Bioassay and Potency Testing Product Portfolio
  12. 7.2.5 Vimta Labs Ltd. Recent Developments
  13. 7.3 WaveCyte BioLabs
  14. 7.3.1 WaveCyte BioLabs Company Information
  15. 7.3.2 WaveCyte BioLabs Business Overview
  16. 7.3.3 WaveCyte BioLabs Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 WaveCyte BioLabs Bioassay and Potency Testing Product Portfolio
  18. 7.3.5 WaveCyte BioLabs Recent Developments
  19. 7.4 Reaction Biology
  20. 7.4.1 Reaction Biology Company Information
  21. 7.4.2 Reaction Biology Business Overview
  22. 7.4.3 Reaction Biology Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Reaction Biology Bioassay and Potency Testing Product Portfolio
  24. 7.4.5 Reaction Biology Recent Developments
  25. 7.5 Charles River Laboratories
  26. 7.5.1 Charles River Laboratories Company Information
  27. 7.5.2 Charles River Laboratories Business Overview
  28. 7.5.3 Charles River Laboratories Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Charles River Laboratories Bioassay and Potency Testing Product Portfolio
  30. 7.5.5 Charles River Laboratories Recent Developments
  31. 7.6 Intertek
  32. 7.6.1 Intertek Company Information
  33. 7.6.2 Intertek Business Overview
  34. 7.6.3 Intertek Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Intertek Bioassay and Potency Testing Product Portfolio
  36. 7.6.5 Intertek Recent Developments
  37. 7.7 Pacific BioLabs
  38. 7.7.1 Pacific BioLabs Company Information
  39. 7.7.2 Pacific BioLabs Business Overview
  40. 7.7.3 Pacific BioLabs Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pacific BioLabs Bioassay and Potency Testing Product Portfolio
  42. 7.7.5 Pacific BioLabs Recent Developments
  43. 7.8 FyoniBio
  44. 7.8.1 FyoniBio Company Information
  45. 7.8.2 FyoniBio Business Overview
  46. 7.8.3 FyoniBio Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 FyoniBio Bioassay and Potency Testing Product Portfolio
  48. 7.8.5 FyoniBio Recent Developments
  49. 7.9 Svar Life Science
  50. 7.9.1 Svar Life Science Company Information
  51. 7.9.2 Svar Life Science Business Overview
  52. 7.9.3 Svar Life Science Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Svar Life Science Bioassay and Potency Testing Product Portfolio
  54. 7.9.5 Svar Life Science Recent Developments
  55. 7.10 Solvias
  56. 7.10.1 Solvias Company Information
  57. 7.10.2 Solvias Business Overview
  58. 7.10.3 Solvias Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Solvias Bioassay and Potency Testing Product Portfolio
  60. 7.10.5 Solvias Recent Developments
  61. 7.11 Bioassay GmbH
  62. 7.11.1 Bioassay GmbH Company Information
  63. 7.11.2 Bioassay GmbH Business Overview
  64. 7.11.3 Bioassay GmbH Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Bioassay GmbH Bioassay and Potency Testing Product Portfolio
  66. 7.11.5 Bioassay GmbH Recent Developments
  67. 7.12 Clean Cells
  68. 7.12.1 Clean Cells Company Information
  69. 7.12.2 Clean Cells Business Overview
  70. 7.12.3 Clean Cells Bioassay and Potency Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Clean Cells Bioassay and Potency Testing Product Portfolio
  72. 7.12.5 Clean Cells Recent Developments
8 North America
  1. 8.1 North America Bioassay and Potency Testing Revenue (2021-2032)
  2. 8.2 North America Bioassay and Potency Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Bioassay and Potency Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Bioassay and Potency Testing Revenue by Type (2027-2032)
  5. 8.3 North America Bioassay and Potency Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Bioassay and Potency Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Bioassay and Potency Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Bioassay and Potency Testing Revenue by Application (2027-2032)
  9. 8.5 North America Bioassay and Potency Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Bioassay and Potency Testing Revenue by Country
  11. 8.6.1 North America Bioassay and Potency Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bioassay and Potency Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Bioassay and Potency Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Bioassay and Potency Testing Revenue (2021-2032)
  2. 9.2 Europe Bioassay and Potency Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bioassay and Potency Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bioassay and Potency Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Bioassay and Potency Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bioassay and Potency Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bioassay and Potency Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bioassay and Potency Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Bioassay and Potency Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bioassay and Potency Testing Revenue by Country
  11. 9.6.1 Europe Bioassay and Potency Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bioassay and Potency Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bioassay and Potency Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Bioassay and Potency Testing Revenue (2021-2032)
  2. 10.2 China Bioassay and Potency Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Bioassay and Potency Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Bioassay and Potency Testing Revenue by Type (2027-2032)
  5. 10.3 China Bioassay and Potency Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Bioassay and Potency Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Bioassay and Potency Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Bioassay and Potency Testing Revenue by Application (2027-2032)
  9. 10.5 China Bioassay and Potency Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bioassay and Potency Testing Revenue (2021-2032)
  2. 11.2 Asia Bioassay and Potency Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bioassay and Potency Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bioassay and Potency Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Bioassay and Potency Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bioassay and Potency Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bioassay and Potency Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bioassay and Potency Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Bioassay and Potency Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bioassay and Potency Testing Revenue by Country
  11. 11.6.1 Asia Bioassay and Potency Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bioassay and Potency Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bioassay and Potency Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bioassay and Potency Testing Revenue (2021-2032)
  2. 12.2 SAMEA Bioassay and Potency Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bioassay and Potency Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bioassay and Potency Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bioassay and Potency Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bioassay and Potency Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bioassay and Potency Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bioassay and Potency Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bioassay and Potency Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bioassay and Potency Testing Revenue by Country
  11. 12.6.1 SAMEA Bioassay and Potency Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bioassay and Potency Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bioassay and Potency Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst